Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Hematology 2 Lec > MPD > Flashcards

MPD Flashcards

1
Q

CHRONIC MYELOPROLIFERATIVE DISORDERS: Recognized by WHO

A

1) Chronic Myeloid Leukemia
2) Chronic Neutrophilic Leukemia
3) Polycythemia vera
4) Primary myelofibrosis
5) Essential thrombocythemia
6) MPN with eosinophilia (and abnormalities of PDGFRA, PDGFRB, FGFRI)
7) Chronic eosinophilic leukemia
8) Mastocytosis
9) Myeloproliferative neoplasm, unclassifiable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Middle-aged (25-40 yrs old)

A

CHRONIC MYELOLOGENOUS LEUKEMIA (CML)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

BCR-ABL present

A

CHRONIC MYELOLOGENOUS LEUKEMIA (CML)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

t(9:22)(q34;q11) BCR-ABL1

A

CHRONIC MYELOLOGENOUS LEUKEMIA (CML)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Dependent on response to TKI

A

CHRONIC MYELOLOGENOUS LEUKEMIA (CML)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Older adults (>40 yrs old)

A

CHRONIC NEUTROPHILIC LEUKEMIA (CNL)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Neutrophilia > 2,000/uL

A

CHRONIC NEUTROPHILIC LEUKEMIA (CNL)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

CSF3R mutation

A

CHRONIC NEUTROPHILIC LEUKEMIA (CNL)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Indolent

A

CHRONIC NEUTROPHILIC LEUKEMIA (CNL)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Middleaged, M > F (25 to early 40s)

A

POLYCYTHEMIA VERA (PV)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Major criteria: Hb >18.5 g/dL in M or >16.5 g/dL; mutation in JAK2 V617F
 confirmatory

A

POLYCYTHEMIA VERA (PV)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Minor criteria: hypercellular marrow with panmyelosis; ↓EPO; ↑endogenous erythroid colony formation in vitro; 2 major plus 1 minor, or first major plus 2 minor criteria

A

POLYCYTHEMIA VERA (PV)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

JAK2 V617F, negative t(9;22)

A

POLYCYTHEMIA VERA (PV)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

10-20 years

A

POLYCYTHEMIA VERA (PV)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

> 50 years

A

PRIMARY MYELOFIBROSIS (PMF)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Major criteria: megakaryocyte proliferation/atypia with marrow fibrosis; CML, PV, MDS ruled out; JAK2 V617F

A

PRIMARY MYELOFIBROSIS (PMF)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

 CML, PV: thrombocytosis
 CML: BCR-ABL
 PV: inc rbc
 MDS: dysplastic megakaryocyte lineage

A

PRIMARY MYELOFIBROSIS (PMF)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Minor criteria: leukoerythroblastosis, ↑LD, anemia, splenomegaly; all 3 major plus 2 minor criteria

A

PRIMARY MYELOFIBROSIS (PMF)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

+8, +9, del(20q), del(13q), del(1p), negative t(9;22)

A

PRIMARY MYELOFIBROSIS (PMF)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Dependent on phase: ≈10 years in early prefibrotic phase (infiltration of cells); ≈5 years in fibrotic phase; 10-15 years before death

A

PRIMARY MYELOFIBROSIS (PMF)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

→ Poikilocyte: Tear-drop cell

A

POLYCYTHEMIA VERA (PV)
PRIMARY MYELOFIBROSIS (PMF)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

5th decade/5 mos old (M = F), second peak in 30s (F > M)

A

ESSENTIAL/PRIMARY THROMBOCYTOSIS (ET)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Platelet count >450,000 (N: 200, 000-400,000); BM with proliferation of mature megakaryocytes; PV, PMF, CML, MDS ruled out; JAK2 V617F

A

ESSENTIAL/PRIMARY THROMBOCYTOSIS (ET)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

CML: proliferation of granulocytes
PMF: myelofibrosis
PV: inc rbc

A

ESSENTIAL/PRIMARY THROMBOCYTOSIS (ET)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

NOTE: All four criteria must be met.

A

ESSENTIAL/PRIMARY THROMBOCYTOSIS (ET)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

JAK2 V617F in 50%

A

ESSENTIAL/PRIMARY THROMBOCYTOSIS (ET)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

del(13q22), +8, +9 seen in 5%-10% of cases

A

ESSENTIAL/PRIMARY THROMBOCYTOSIS (ET)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

negative t(9;22)

A

ESSENTIAL/PRIMARY THROMBOCYTOSIS (ET)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Stable for many years (most cases)

A

ESSENTIAL/PRIMARY THROMBOCYTOSIS (ET)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

→ May have symptoms of anemia and rapid weight loss

A
  1. CHRONIC MYELOLOGENOUS LEUKEMIA (CML)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

→ May complain of malaise (night sweats)

A
  1. CHRONIC MYELOLOGENOUS LEUKEMIA (CML)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

 due to high wbc/granulocyte turn over (1 hour instead of <20 days)

A
  1. CHRONIC MYELOLOGENOUS LEUKEMIA (CML)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

→ Spleen enlarges progressively resulting to high fever and night sweats (Splenomegaly)

A
  1. CHRONIC MYELOLOGENOUS LEUKEMIA (CML)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

 due to high fever and night sweats

A
  1. CHRONIC MYELOLOGENOUS LEUKEMIA (CML)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

→ (Latent) Excessive bleeding or bruising

A
  1. CHRONIC MYELOLOGENOUS LEUKEMIA (CML)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

 internal bleeding and abnormal coagulation

A
  1. CHRONIC MYELOLOGENOUS LEUKEMIA (CML)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

→ Lymphadenopathy

A
  1. CHRONIC MYELOLOGENOUS LEUKEMIA (CML)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

 swollen lymph glands; enlargement of lymph nodes due to viral infection

A
  1. CHRONIC MYELOLOGENOUS LEUKEMIA (CML)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

 prone to mild-severe infections

A
  1. CHRONIC MYELOLOGENOUS LEUKEMIA (CML)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

→ WBC ct: over 5x109/L (may exceed 30x109/L)

A
  1. CHRONIC MYELOLOGENOUS LEUKEMIA (CML)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

 normal: 4-11x109/L

A
  1. CHRONIC MYELOLOGENOUS LEUKEMIA (CML)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

 Neutrophil peak (makes up 70% of wbc)

A
  1. CHRONIC MYELOLOGENOUS LEUKEMIA (CML)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

 Present: Basophilia and Eosinophilia, and Increased Monocytes

A
  1. CHRONIC MYELOLOGENOUS LEUKEMIA (CML)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

 Absent: Llymphocytes → anemia is present

A
  1. CHRONIC MYELOLOGENOUS LEUKEMIA (CML)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

 Normocytic anemia: normal shape, size and color, but few

A
  1. CHRONIC MYELOLOGENOUS LEUKEMIA (CML)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

 Thrombocytosis is very common

A
  1. CHRONIC MYELOLOGENOUS LEUKEMIA (CML)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

→ Marrow: Markedly hypercellular

A
  1. CHRONIC MYELOLOGENOUS LEUKEMIA (CML)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

 viscous blood (same ass dehydration) = difficulty in aspiration of bm = bm biopsy o due to reticulin

A
  1. CHRONIC MYELOLOGENOUS LEUKEMIA (CML)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

 hypercellularity is due to dense cell and increased reticulin

A
  1. CHRONIC MYELOLOGENOUS LEUKEMIA (CML)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

 exhibits Macrophages Laden/Sea-blue histiocytes appearance (normally: light)

A
  1. CHRONIC MYELOLOGENOUS LEUKEMIA (CML)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

→ NAP (Neutrophil Alkaline Phosphatase): reduced or absent

A
  1. CHRONIC MYELOLOGENOUS LEUKEMIA (CML)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

 Enzyme found in neutrophils

A
  1. CHRONIC MYELOLOGENOUS LEUKEMIA (CML)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

 Not seen in CML due to dysmyelopoiesis (abnormal neut prod)

A
  1. CHRONIC MYELOLOGENOUS LEUKEMIA (CML)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

 ↑wbc turn over rate, proliferation of neutrophil, basophil, eosinophil = abnormal wbc = genetic problem in the production of granulocytes

A
  1. CHRONIC MYELOLOGENOUS LEUKEMIA (CML)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

 Hallmark of CML

A
  1. CHRONIC MYELOLOGENOUS LEUKEMIA (CML)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

→ Cytogenetic abnormalities: Ph chromosome (Philadelphia)

A
  1. CHRONIC MYELOLOGENOUS LEUKEMIA (CML)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

 abnormal type of chromosome present in px w/ CML

A

Ph chromosome (Philadelphia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

 Cause: mutation of both ABL-1 gene of Ch 9 and BCR gene of Ch 22

A

Ph chromosome (Philadelphia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

abnormal chromosome containing the abnormal gene

A

Ph chromosome (Philadelphia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

: abnormal gene

A

 BCR-ABL gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

 Etiolgy:

A

from Ch 9 and Ch 22 abnormalities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

→ Prognosis: TKl targets BCR-ABL and results in long term remissions.

A
  1. CHRONIC MYELOLOGENOUS LEUKEMIA (CML)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

 Dependent of response to TKI (cytokine supressed targeting BCR-ABL gene; appearance causes long-term remission of CML)

A
  1. CHRONIC MYELOLOGENOUS LEUKEMIA (CML)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

 in chemotherapy, TKI is supressed to supress the mutation on Ch 9 and Ch 22

A
  1. CHRONIC MYELOLOGENOUS LEUKEMIA (CML)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
65
Q

→ Progression: aggressive; marrow blast increases from 10% to 19%, >20% basophilia, thrombocytosis >100, leukocytosis and splenomegaly, dysplasia of megakaryocytes and reticulin fibrosis

A
  1. CHRONIC MYELOLOGENOUS LEUKEMIA (CML)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
66
Q

 From 10% blasts to 19%

A
  1. CHRONIC MYELOLOGENOUS LEUKEMIA (CML)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
67
Q

: progression to AML (short month-lifespan)

A

> 20% blast
70% of T and B lineage

68
Q

 >20% of persistent basophilia

A
  1. CHRONIC MYELOLOGENOUS LEUKEMIA (CML)
69
Q

 Thrombocytosis: >1 million (normal: 200-450)

A
  1. CHRONIC MYELOLOGENOUS LEUKEMIA (CML)
70
Q

 Splenomegaly

A
  1. CHRONIC MYELOLOGENOUS LEUKEMIA (CML)
71
Q

 Reticulin fibrosis: abnormal prod of reticulin causing fibrotic bm

A
  1. CHRONIC MYELOLOGENOUS LEUKEMIA (CML)
72
Q

 70% of T and B lineage appears

A
  1. CHRONIC MYELOLOGENOUS LEUKEMIA (CML)
73
Q

Lymphocyte does not appear in the circulation

A
  1. CHRONIC MYELOLOGENOUS LEUKEMIA (CML)
74
Q

→ Blast phase progresses to AML (>20% blast in blood or BM, aggregates extramedullary, myeloid lineage encompasses 70% of cells, occasionally B and T lineage appears)

A
  1. CHRONIC MYELOLOGENOUS LEUKEMIA (CML)
75
Q

Serum cobalamin and transcobalamin: increased

A
  1. CHRONIC MYELOLOGENOUS LEUKEMIA (CML)
76
Q

is required for normal segmentation of wbc

A

Vit B12 (cobalamin)

77
Q

Inc prod of granulocytes

A

Serum cobalamin and transcobalamin

78
Q

 Serum muramidase (lysozyme): increased

A
  1. CHRONIC MYELOLOGENOUS LEUKEMIA (CML)
79
Q

Enzyme found in granulocytes

A

Serum muramidase

80
Q

 Ph Ch positive (w/ neutrophilia)

A
  1. CHRONIC MYELOLOGENOUS LEUKEMIA (CML)
81
Q

→ Persistent and unexplained (no cause) neutrophilia (>25x109/L) and mature granulocytes

A
82
Q

 Normally happens w/ bacterial infection

A
83
Q

 No infection that preceded the disease

A
84
Q

→ Resembles: reactive neutrophilia

A
85
Q

 Infection: wbc reacts with microorganism

A
86
Q

→ Associated conditions:
a. Splenomegaly
b. Hepatomegaly
c. Mucocutaneous bleeding

A
87
Q

: liver becomes overworked in the production of proteins needed in neutrophil production

A

b. Hepatomegaly

88
Q

: components under the skin (outside the bv) does not normally interact w/ neutrophil; causes appearance of pus

A

c. Mucocutaneous bleeding

89
Q

: inflammation of the joint

A

Pruritis/gout

90
Q

→ Left shift with bands and toxic granulation

A
  1. CHRONIC NEUTROPHILIC LEUKEMIA (CNL)
91
Q

→ BM findings: Hypercellularity with granulocytes (neutrophil)

A
  1. CHRONIC NEUTROPHILIC LEUKEMIA (CNL)
92
Q

 M:E → 20:1
Normal M:E → 3 wbc : 1 rbc

A
  1. CHRONIC NEUTROPHILIC LEUKEMIA (CNL)
93
Q

Due to hyperplastic granulocytic lineage

A
  1. CHRONIC NEUTROPHILIC LEUKEMIA (CNL)
94
Q

*Predominance of mature neutrophils to myelocytes.

A
  1. CHRONIC NEUTROPHILIC LEUKEMIA (CNL)
95
Q

→ Cytogenetic abnormalities: includes +8, +9, del (20q) and del (11q)

A
  1. CHRONIC NEUTROPHILIC LEUKEMIA (CNL)
96
Q

 Hyperplasia (not dysplasia)

A
  1. CHRONIC NEUTROPHILIC LEUKEMIA (CNL)
97
Q

 Mutation on CSF3R gene

A
  1. CHRONIC NEUTROPHILIC LEUKEMIA (CNL)
98
Q

→ Prognosis: Indolent

A
  1. CHRONIC NEUTROPHILIC LEUKEMIA (CNL)
99
Q

 progressing slowly; not life threatening
 does not progress to AML

A
  1. CHRONIC NEUTROPHILIC LEUKEMIA (CNL)
100
Q

→ Affects erythroid lineage

A
  1. POLYCYTHEMIA VERA (PV)
101
Q

 increased RBC; abnormal proliferation

A
  1. POLYCYTHEMIA VERA (PV)
102
Q

→ Panmyelosis

A
  1. POLYCYTHEMIA VERA (PV)
103
Q

 increase in all bone marrow cell (wbc, megakaryocyte)

A
  1. POLYCYTHEMIA VERA (PV)
104
Q

 increased only (not marked or pronounced)

A
  1. POLYCYTHEMIA VERA (PV)
105
Q

→ Absolute increase in red cell mass, leukocytosis and thrombocytosis

A
  1. POLYCYTHEMIA VERA (PV)
106
Q

 ESR increased

A
  1. POLYCYTHEMIA VERA (PV)
107
Q

→ Serum and urine EPO is DECREASED or NORMAL

A
  1. POLYCYTHEMIA VERA (PV)
108
Q

 Will not cause stimulation but proliferation of red cell in the bm

A
  1. POLYCYTHEMIA VERA (PV)
109
Q

→ Proliferation of erythrocytes is autonomous with EECs (endogenous erythroid colonies)

A
  1. POLYCYTHEMIA VERA (PV)
110
Q

 Abnormal cells in the bm that produces rbc w/o stimulation from EPO

A
  1. POLYCYTHEMIA VERA (PV)
111
Q

 increased causing proliferation of rbc w/o EPO

A
  1. POLYCYTHEMIA VERA (PV)
112
Q

→ Frequency: men

A
  1. POLYCYTHEMIA VERA (PV)
113
Q

→ Cyanosis is present

A
  1. POLYCYTHEMIA VERA (PV)
114
Q

 Bluish/pale discoloration of the skin

A
  1. POLYCYTHEMIA VERA (PV)
115
Q

 Red cells cannot deliver oxygen since they are very saturated in the circulation = very viscous blood

A
  1. POLYCYTHEMIA VERA (PV)
116
Q

→ Splenomegaly is present

A
  1. POLYCYTHEMIA VERA (PV)
117
Q

 Accommodates extra red cells in the circulation instead of platelet

A
  1. POLYCYTHEMIA VERA (PV)
118
Q

→ Thrombosis is most common
 Due to inc cells in the bm

A
  1. POLYCYTHEMIA VERA (PV)
119
Q

→ GIT bleeding is common as well as Pruritus

A
  1. POLYCYTHEMIA VERA (PV)
120
Q

 Joint cavity is inflamed (accumulation of rbc in the joints)

A

Pruritus

121
Q

 Aka Gout

A

Pruritus

122
Q

→ RBC count: >6-10x1012/L

A
  1. POLYCYTHEMIA VERA (PV)
123
Q

→ Hemoglobin: >18.5 (M) ; >16.5 (F)

A
  1. POLYCYTHEMIA VERA (PV)
124
Q

→ Hypochromic and microcytic if chronic blood loss has occurred

A
  1. POLYCYTHEMIA VERA (PV)
125
Q

 Iron is depleted

A
  1. POLYCYTHEMIA VERA (PV)
126
Q

→ Production: increased

A
  1. POLYCYTHEMIA VERA (PV)
127
Q

→ Destruction: decreased

A
  1. POLYCYTHEMIA VERA (PV)
128
Q

 Accumulation of rbc in the circulation

A
  1. POLYCYTHEMIA VERA (PV)
129
Q

→ Upon progression: splenomegaly (chronic; after 1year of the disease); decreased survival (macrophages in the spleen destroys rbc)

A
  1. POLYCYTHEMIA VERA (PV)
130
Q

→ Blood volume: increased

A
  1. POLYCYTHEMIA VERA (PV)
131
Q

→ ESR: increased

A
  1. POLYCYTHEMIA VERA (PV)
132
Q

→ PIatelet count: 1000x109/L

A
  1. POLYCYTHEMIA VERA (PV)
133
Q

→ WBC: neutrophilic leukocytosis with immature granulocyte

A
  1. POLYCYTHEMIA VERA (PV)
134
Q

→ Hyperuricemia is common with increased nucleic acid metabolism

A
  1. POLYCYTHEMIA VERA (PV)
135
Q

 Due to increased uric acid from increased DNA and RNA metabolism (protein is broken down = NA, RNA, DNA = waste product: uric acid → liver & kidneys to be excreted ≠ returns to the circulation = accumulation of uric acid in the joints = gout)

A
  1. POLYCYTHEMIA VERA (PV)
136
Q

 inc rbc = inc retic = inc RNA remnants (accumulated to waste prods)

A
  1. POLYCYTHEMIA VERA (PV)
137
Q

→ BM: moderate-to-markedly hypercellular with prominent normoblastic erythroid hyperplasia and panmyelosis

A
  1. POLYCYTHEMIA VERA (PV)
138
Q

→ lncreased reticulin (makes the blood viscous; present in the bm)

A
  1. POLYCYTHEMIA VERA (PV)
139
Q

→ Storage iron is decreased to absent

A
  1. POLYCYTHEMIA VERA (PV)
140
Q

→ Major criteria for diagnosis:
1) Hemoglobin
2) Presence of mutation (JAK12, exon 12)

A
  1. POLYCYTHEMIA VERA (PV)
141
Q

→ Prognosis: 10–20 years

A
  1. POLYCYTHEMIA VERA (PV)
142
Q

→ Progression: Anemia (chance: 20-40%)

A
  1. POLYCYTHEMIA VERA (PV)
143
Q

 proliferation of rbc = decreased survival

A
  1. POLYCYTHEMIA VERA (PV)
144
Q

 CML & CNL → AML ; PV → Anemia

A
  1. POLYCYTHEMIA VERA (PV)
145
Q

 normal response to blood loss (inc in plt = blood clot : first responder in coagulation)

A

ESSENTIAL/PRIMARY THROMBOCYTOSIS (ET)

146
Q

 requires a lot of plt = inc plt = reactive thrombocytosis (blood loss/excessive bleeding)

A

ESSENTIAL/PRIMARY THROMBOCYTOSIS (ET)

147
Q

 abnormal increase of plt w/o stimulation of TBO

A

ESSENTIAL/PRIMARY THROMBOCYTOSIS (ET)

148
Q

▪ disorders that show features of both myelodysplastic and myeloproliferative disorders

A

MYELODYSPLSTIC/MYELOPROLIFERATIVE DISORDERS

149
Q

▪ characterized by increases in cells as well as cytopenia and morphologic dysplasia

A

MYELODYSPLSTIC/MYELOPROLIFERATIVE DISORDERS

150
Q

MYELODYSPLSTIC/MYELOPROLIFERATIVE DISORDERS:

A
151
Q

Normal:

A

CML starts w/ dysplastic refractory cytopenia due to inc apoptosis (supressed in late stages of MDS) = proliferation of abnormal neutrophil → CNL → Lekukemia

152
Q

• persistent monocytosis of > 1 x 109 /L for more than 3 months

A
  1. CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
153
Q

• with 20% blasts and promonocytes in the PB and BM

A
  1. CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
154
Q

• with dysplasia in one or more myeloid cell line

A
  1. CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
155
Q

• positive (+): - alpha naphthyl acetate, alpha naphthyl butyrate esterase

→ monocytes usually react with both stains

A
  1. CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
156
Q
  • < 5% blasts and promonocytes in the PB
A

CMML-1

157
Q
  • < 10% in the BM
A

CMML-1

158
Q

(more severe):

A

CMML-2

159
Q
  • 5%-19% blasts and promonocytes in the PB
A

CMML-2

160
Q
  • 10%-19% in the BM
A

CMML-2

161
Q

▪ characterized by leukocytosis (↑mature and immature neutrophils) with prominent dysgranulopoiesis (abnormal/defective structure production of WBCs)

A
  1. ATYPICAL CHRONIC MYELOID LEUKEMIA (ACML), BCR-ABL1 NEGATIVE
162
Q

▪ BCR-ABL1 negative

A
  1. ATYPICAL CHRONIC MYELOID LEUKEMIA (ACML), BCR-ABL1 NEGATIVE
163
Q

▪ predominantly granulocytic (BEN) and monocytic lineages

A
  1. JUVENILE MYELOMONOCYTIC LEUKEMIA (JMML)
164
Q

Ph negative CML

A
  1. JUVENILE MYELOMONOCYTIC LEUKEMIA (JMML)
165
Q

Monosomy 7

A
  1. JUVENILE MYELOMONOCYTIC LEUKEMIA (JMML)

Hematology 2 Lec (29 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions